|
CWC27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.788100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.977500E-04 |
| Normal-vs-Stage2 |
9.999000E-04 |
| Normal-vs-Stage3 |
1.661590E-01 |
| Normal-vs-Stage4 |
3.019600E-01 |
| Stage1-vs-Stage2 |
5.784000E-01 |
| Stage1-vs-Stage3 |
3.732200E-01 |
| Stage1-vs-Stage4 |
4.241000E-01 |
| Stage2-vs-Stage3 |
2.391800E-01 |
| Stage2-vs-Stage4 |
1.935190E-01 |
| Stage3-vs-Stage4 |
8.514200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.759800E-04 |
| Normal-vs-AfricanAmerican |
3.886400E-02 |
| Normal-vs-Asian |
5.656800E-01 |
| Caucasian-vs-AfricanAmerican |
4.523200E-01 |
| Caucasian-vs-Asian |
4.441200E-01 |
| AfricanAmerican-vs-Asian |
6.721800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13350000000112E-06 |
| Normal-vs-Female |
9.589600E-01 |
| Male-vs-Female |
2.21360000000059E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.939900E-03 |
| Normal-vs-Extreme_Weight |
1.179980E-04 |
| Normal-vs-Obese |
6.822400E-02 |
| Normal-vs-Extreme_Obese |
1.319620E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.204800E-01 |
| Normal_Weight-vs-Obese |
3.265400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.037200E-01 |
| Extreme_Weight-vs-Obese |
7.593500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.968200E-01 |
| Obese-vs-Extreme_Obese |
3.976200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.774000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.760100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.92127999999459E-05 |
| Normal-vs-Age(81-100Yrs) |
7.181600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.741600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.296770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.550200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.615530E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.885400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.43060000000495E-05 |
| Normal-VS-Type2 PRCC |
6.975500E-03 |
| Normal-VS-KIRP CIMP |
1.724360E-01 |
| Normal-VS-Unclassified PRCC |
2.304400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.021200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.239800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.222830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.972400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.356800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.108200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.849600E-04 |
| Normal-vs-N1 |
9.296000E-01 |
| Normal-vs-N2 |
8.872200E-01 |
| N0-vs-N1 |
1.734470E-02 |
| N0-vs-N2 |
2.595000E-01 |
| N1-vs-N2 |
9.629400E-01 |
|
|
